In the ongoing battle between the natural and synthetic influences on our lives, careful observers may notice that Mother Nature has been slowly but surely gaining some foot holds in the ever present and ever expanding land of Big Pharm. I would like to bring your attention to yet another recent study that has planted a good size foot down on BP’s diabetes territory. Here is an article about a study that compared the impact of EGCG (Epigallocatechin 3-gallate) with that of GlaxoSmithKline’s Avandia drug for managing moderate diabetes.

The study was done with mice and showed that the EGCG extract provided as much benefit to the moderately diabetic mice as did the Avandia. Although not a human study, it does continue to add to the growing body of evidence showing that regular consumption of tea helps to control insulin and glucose levels. This is just another notch on the research belt of how tea can help prevent and improve the health of people with mild to moderate diabetes. Imagine the benefit to those that are pre-diabetic!